NuCana plc (NCNA) stock
NCNANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.86−0.07 (-7.53%)
Close on Nov 16, 2026Market cap $3.58MP/E –Yield –
NuCana operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
NuCana's operating cash flow for the twelve months ending Dec 31, 2021 was -£23.82M. For fiscal 2025 it was -£7.47M. The highest annual figure on record is -£4.47M in fiscal 2015.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -£7.47M | – |
| FY2024 | Dec 31, 2024 | -£19.12M | – |
| FY2023 | Dec 31, 2023 | -£26.44M | – |
| FY2022 | Dec 31, 2022 | -£23.16M | – |
| FY2021 | Dec 31, 2021 | -£23.82M | – |
| FY2020 | Dec 31, 2020 | -£21.62M | – |
| FY2019 | Dec 31, 2019 | -£23.83M | – |
| FY2018 | Dec 31, 2018 | -£12.22M | – |
| FY2017 | Dec 31, 2017 | -£8.71M | – |
| FY2016 | Dec 31, 2016 | -£9.26M | – |
| FY2015 | Dec 31, 2015 | -£4.47M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2021 | Dec 31, 2021 | -£10.09M | – |
| Q3 FY2021 | Sep 30, 2021 | -£805.00K | – |
| Q2 FY2021 | Jun 30, 2021 | -£4.86M | – |
| Q1 FY2021 | Mar 31, 2021 | -£8.07M | – |
| Q4 FY2020 | Dec 31, 2020 | -£8.98M | – |
| Q3 FY2020 | Sep 30, 2020 | -£4.99M | – |
| Q2 FY2020 | Jun 30, 2020 | -£1.44M | – |
| Q1 FY2020 | Mar 31, 2020 | -£6.21M | – |
| Q4 FY2019 | Dec 31, 2019 | -£3.86M | – |
| Q3 FY2019 | Sep 30, 2019 | -£8.34M | – |
| Q2 FY2019 | Jun 30, 2019 | -£5.54M | – |
| Q1 FY2019 | Mar 31, 2019 | -£6.09M | – |
| Q4 FY2018 | Dec 31, 2018 | -£2.34M | – |
| Q3 FY2018 | Sep 30, 2018 | -£3.99M | – |
| Q2 FY2018 | Jun 30, 2018 | -£3.14M | – |
| Q1 FY2018 | Mar 31, 2018 | -£2.76M | – |
| Q4 FY2017 | Dec 31, 2017 | -£3.18M | – |
| Q3 FY2017 | Sep 30, 2017 | -£1.94M | – |
See a number that looks wrong?